–
The deadline for submitting an abstract is 15 March 2024 (12 PM CET).
Early bird registration is until 20 March 2024.
From the organizers:
LIVe2024 intends to be a unique exchange platform for scientists interested in in vitro respiratory researches, stakeholders from academia, pharma, biotech, chemical, tobacco, consumer goods, medical devices industries, CROs and regulatory agencies.
The meeting focuses on predictive in vitro lung models designed for basic research, efficacy and toxicity testing. It aims at presenting the use of state-of-the-art in vitro lung models including ALI reconstructed epithelia, organoids, PCLSs, lung-on-a-chips made of cell lines, IPSCs, primary respiratory and immune cells for the following themes:
1. Modeling COPD/Asthma/IPF/CF/CPD in vitro
2. Viral Infections
3. Bacterial Infections and Fungal Infections
4. Inhalation Toxicity Testing
5. Biological Barriers & Drug Delivery
6. Exposure Devices and Deposition Modelling
7. Mucus, Surfactant, Cilia Functions and Modulations
8. Think Different